Essex Bio-Technology Limited
1061.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.22B
Close$
Share Statistics
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $759.26 Million |
| Dividend Yield | $0.12 (5.58%) |
| Earnings per Share | $0.56 |
| Beta | 0.02 |
| Outstanding Shares | 566,971,492 |
Return
| Return on Equity | 22.70% |
|---|---|
| Return on Assets | 16.00% |
| Return on Invested Capital | 25.67% |
Valuation & Multiples
| P/E Ratio | 4.57 |
|---|---|
| PEG | -14.19 |
| Price to Sales | 0.35 |
| Price to Book Ratio | 0.52 |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | 1.04 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 1, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$784.69 M
Average shareholder expectationNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$800.66 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Essex Bio-Technology Limited
1,240 employees
CEO: Hian Leng Ngiam Essex Bio-Technology Limited operates as an investment holding company, specializing in the development, manufacturing, distribution, and sale of biopharmaceutical products. Its business activities extend across the People's Republic of ...